| Literature DB >> 35452480 |
Rebekah R Koehn1, Sarah A Roelker2, Xueliang Pan3, Laura C Schmitt4,5,6, Ajit M W Chaudhari1,4,5,6,7,8, Robert A Siston1,4,5,7,8.
Abstract
BACKGROUND: Individuals who undergo total knee arthroplasty (TKA) for treatment of knee osteoarthritis often experience suboptimal outcomes. Investigation of neuromuscular control strategies in these individuals may reveal factors that contribute to these functional deficits. The purpose of this pilot study was to determine the relationship between patient function and modular control during gait before and after TKA.Entities:
Mesh:
Year: 2022 PMID: 35452480 PMCID: PMC9032423 DOI: 10.1371/journal.pone.0267340
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Demographics, modules, and function.
| Patient Population; n = 38 | Healthy Controls | Between Populations | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-TKA | 6-months Post-TKA | 24-months Post-TKA | Between Time Points (GLMM) | (t-test or Chi-square test) | |||||
| n = 30 | n = 26 | n = 13 |
| F | n = 10 |
| t/ | ||
| Demographics | Sex | 13M, 17F | 9M, 17F | 5M, 8F | - | - | 5M, 5F | - | - |
| Height (m) | 1.70 ± 0.10 | 1.67 ± 0.10 | 1.69 ± 0.11 | 0.611 | F2,66 = 0.50 | 1.69 ± 0.08 | 0.906 | t21 = -0.12 | |
| Age (y) | 59.7 ± 7.8 | 60.3 ± 7.0 | 61.9 ± 6.9 | - | - | 63.5 ± 3.4 | 0.227 | t21 = 1.24 | |
| Mass (kg) | 96.3 ± 18.7 | 96.8 ± 20.3 | 100.5 ± 20.4 | 0.124 | F2,13 = 2.46 | 71.5 ± 13.5 |
| ||
| BMI (kg/m2) | 33.7 ± 5.1 | 34.0 ± 5.7 | 35.5 ± 6.4 |
| 24.8 ± 2.6 |
| |||
| Walking Speed (m/s) | 0.97 ± 0.26 | 1.11 ± 0.22 | 1.22 ± 0.13 |
| 1.12 ± 0.18 | 0.145 | t21 = -1.51 | ||
| Normalized Stride Length (m/m) | 1.42 ± 0.25 | 1.53 ± 0.24 | 1.57 ± 0.22 | 0.056 | F2,12 = 3.36 | 1.51 ± 0.16 | 0.248 | t21 = -1.19 | |
| Mods | Number of Modules | 2.5 ± 0.6 | 2.5 ± 0.6 | 2.5 ± 0.5 | 0.844 | F2,18 = 0.17 | 2.7 ± 0.5 | 0.673 | |
| Proper Module Organization | 6 of 30 | 11 of 26 | 6 of 13 | 0.143 | F2,19 = 2.15 | - | - | - | |
| Function Metrics | SCT (s) | 25.7 ± 14.6 | 19.5 ± 8.8 | 18.3 ± 6.8 |
| - | - | - | |
| TUG (s) | 11.5 ± 4.4 | 10.0 ± 1.9 | 8.8 ± 1.8 |
| - | - | - | ||
| 6MW (m) | 401.1 ± 106.9 | 457.9 ± 89.0 | 495.5 ± 78.2 |
| - | - | - | ||
| KOOS-Pain (pts) | 48.7 ± 20.4 | 73.7 ± 22.2 | 79.6 ± 15.5 |
| - | - | - | ||
| KOOS-Symptoms (pts) | 46.4 ± 21.2 | 63.6 ± 18.7 | 72.3 ± 15.9 |
| - | - | - | ||
| KOOS-ADL (pts) | 55.8 ± 20.8 | 78.2 ± 21.4 | 80.2 ± 14.1 |
| - | - | - | ||
| KOOS-QOL (pts) | 24.7 ± 21.0 | 54.3 ± 22.2 | 64.1 ± 24.2 |
| - | - | - | ||
Average demographics, module metrics, and function metrics grouped by time point and population (± 1 standard deviation). The healthy control group was compared to the group of participants tested at 24-months post-TKA.
Symbols indicate differences between:
aPre-TKA and 6-months Post-TKA
bPre-TKA and 24-months Post-TKA
c6- and 24-months Post-TKA.
† Clinically meaningful improvement in function compared to the previous time point.
M = male.
F = female.
Fig 1Example of EMG reconstruction using non-negative matrix factorization.
Muscle modules were calculated using non-negative matrix factorization (NMF) in which an m x n Weighting Matrix is multiplied by an n x t Pattern Matrix to reconstruct the EMG patterns in an m x t matrix, where m is the number of muscles (8 in this study), n is the number of modules (3 in this example), and t is the number of data points in the trial (201 in this study). The Pattern Matrix represents the timing profile of each module. The Weighting Matrix represents how strongly each muscle is represented in the module. This process is iterated, increasing n from 1 to m until the error between the reconstructed EMG (black dotted line) and the original EMG (solid gray line) is reduced to some acceptable level determined by the variability accounted for (VAF) criteria.
Fig 2tVAF for all module solutions.
Estimated mean tVAF by time point for number of modules varying from 1 to 8. Error bars represent +1 standard deviation. * indicates statistically significant differences between time points.
Fig 3Performance-based function.
Performance-based functional scores (SCT, TUG, 6MW) for each participant at each time point. Participants who were present for consecutive testing time points are connected. Filled symbols indicate participants with proper module organization. Thick black lines indicate the group estimated means and 95% confidence intervals at each time point, determined by the GLMM. */† = statistically significant (*) and clinically meaningful (†) differences in function between time points. @/# = statistically significant (@) and clinically meaningful (#) differences in function between groups demonstrating the same number of modules at each time point. & = clinically meaningful differences in function between groups demonstrating proper or poor module organization at each time point. There were no statistically significant differences.
Fig 4Patient-reported function.
KOOS survey subscale scores (Pain, Symptoms, ADL, QOL) for each participant at each time point. Participants who were present for consecutive testing time points are connected. Filled symbols indicate participants with proper module organization. Thick black lines indicate the group estimated means and 95% confidence intervals at each time point, determined by the GLMM. */† = statistically significant (*) and clinically meaningful (†) differences in function between time points. @/# = statistically significant (@) and clinically meaningful (#) differences in function between groups demonstrating the same number of modules at each time point. & = clinically meaningful differences in function between groups demonstrating proper or poor module organization at each time point. There were no statistically significant differences.
Functional measures within module number groups.
| Two Modules | Three Modules |
| Estimate | 95% CI | ||
|---|---|---|---|---|---|---|
| Number of Subjects | Pre-TKA | n = 16 | n = 14 | - | - | - |
| 6-months Post-TKA | n = 12 | n = 14 | - | - | - | |
| 24-months Post-TKA | n = 5 | n = 8 | - | - | - | |
| SCT (s) | Pre-TKA | 30.2 ± 15.3 | 21.0 ± 11.2 | 0.060 | 9.2 | [-0.42, 18.90] |
| 6-months Post-TKA | 22.5 ± 11.5 | 16.4 ± 4.2 | 0.052 | 6.1 | [-0.05, 12.19] | |
| 24-months Post-TKA | 16.1 ± 3.6 | 19.5 ± 7.6 | 0.434 | -3.4 | [-12.44, 5.70] | |
| TUG (s) | Pre-TKA | 13.1 ± 5.3 | 9.6 ± 2.3 |
|
|
|
| 6-months Post-TKA | 10.8 ± 2.5 | 9.4 ± 1.4 |
|
|
| |
| 24-months Post-TKA | 9.2 ± 1.9 | 8.9 ± 1.6 | 0.803 | 0.3 | [-2.51, 3.16] | |
| 6MW (m) | Pre-TKA | 379.7 ± 123.8 | 425.9 ± 76.8 | 0.128 | -46.7 | [-107.79, 14.49] |
| 6-months Post-TKA | 453.8 ± 116.3 | 467.9 ± 53.7 | 0.621 | -13.1 | [-67.74, 41.44] | |
| 24-months Post-TKA | 546.1 ± 55.7 | 468.4 ± 48.4 |
|
|
| |
| KOOS-Pain (points) | Pre-TKA | 39.2 ± 16.6 | 58.8 ± 19.8 |
|
|
|
| 6-months Post-TKA | 69.8 ± 24.6 | 78.3 ± 12.4 | 0.186 | -8.6 | [-21.82, 4.67] | |
| 24-months Post-TKA | 80.6 ± 13.5 | 80.7 ± 17.0 | 0.987 | -0.1 | [-19.98, 19.68] | |
| KOOS-Symptom (points) | Pre-TKA | 40.3 ± 18.8 | 52.4 ± 22.5 | 0.152 | -12.1 | [-28.94, 4.72] |
| 6-months Post-TKA | 60.5 ± 19.8 | 67.1 ± 17.3 | 0.393 | -6.6 | [-22.92, 9.71] | |
| 24-months Post-TKA | 79.0 ± 13.8 | 69.2 ± 16.5 | 0.418 | 9.7 | [-15.79, 35.26] | |
| KOOS-ADL (points) | Pre-TKA | 49.1 ± 17.9 | 63.0 ± 22.3 | 0.057 | -13.9 | [-28.17, 0.46] |
| 6-months Post-TKA | 76.4 ± 25.6 | 80.0 ± 9.5 | 0.482 | -3.6 | [-15.35, 8.08] | |
| 24-months Post-TKA | 77.8 ± 12.0 | 83.2 ± 15.9 | 0.520 | -5.4 | [-23.85, 12.98] | |
| KOOS-QOL (points) | Pre-TKA | 17.7 ± 15.0 | 32.3 ± 24.1 | 0.065 | -14.7 | [-30.49, 1.16] |
| 6-months Post-TKA | 57.2 ± 20.0 | 53.1 ± 20.1 | 0.515 | 4.1 | [-9.36, 17.55] | |
| 24-months Post-TKA | 61.7 ± 28.4 | 64.8 ± 22.5 | 0.832 | -3.1 | [-34.98, 28.69] |
Average functional measures within groups of participants demonstrating the same number of modules at each timepoint (estimated mean ± 1 standard deviation).
† Clinically meaningful difference in function between the Two Modules and Three Modules groups.
Functional measures within module organization groups.
| Poor | Proper | p-Value | Estimate | 95% CI | ||
|---|---|---|---|---|---|---|
| Number of Subjects | Pre-TKA | n = 24 | n = 6 | - | - | - |
| 6-months Post-TKA | n = 15 | n = 11 | - | - | - | |
| 24-months Post-TKA | n = 7 | n = 6 | - | - | - | |
| SCT (s) | Pre-TKA | 26.1 ± 14.2 | 24.2 ± 17.3 | 0.750 | 2.0 | [-10.64, 14.60] |
| 6-months Post-TKA | 19.9 ± 10.7 | 19.1 ± 5.4 | 0.824 | 0.7 | [-6.39, 7.88] | |
| 24-months Post-TKA | 19.6 ± 9.3 | 16.2 ± 2.6 | 0.487 | 3.4 | [-7.06, 13.93] | |
| TUG (s) | Pre-TKA | 11.3 ± 4.8 | 12.0 ± 2.5 | 0.695 | -0.6 | [-4.04, 2.78] |
| 6-months Post-TKA | 10.2 ± 1.9 | 9.8 ± 2.0 | 0.679 | 0.3 | [-1.25, 1.88] | |
| 24-months Post-TKA | 8.5 ± 2.3 | 9.2 ± 0.8 | 0.540 | -0.7 | [-3.11, 1.72] | |
| 6MW (m) | Pre-TKA | 401.6 ± 110.3 | 399.9 ± 97.4 | 0.963 | 1.7 | [-75.03, 78.46] |
| 6-months Post-TKA | 454.4 ± 96.2 | 462.2 ± 79.6 | 0.762 | -7.7 | [-60.33, 44.85] | |
| 24-months Post-TKA | 489.3 ± 89.8 | 502.0 ± 69.3 | 0.727 | -12.7 | [-92.51, 67.11] | |
| KOOS-Pain (points) | Pre-TKA | 49.5 ± 19.2 | 46.4 ± 26.8 | 0.729 | 3.2 | [-15.41, 21.74] |
| 6-months Post-TKA | 77.3 ± 19.1 | 68.1 ± 25.7 | 0.116 | 9.2 | [-2.75, 21.19] | |
| 24-months Post-TKA | 75.2 ± 14.6 | 86.1 ± 12.8 | 0.061 | -11.0 | [-22.53, 0.60] | |
| KOOS-Symptom (points) | Pre-TKA | 46.8 ± 19.6 | 45.7 ± 29.1 | 0.920 | 1.1 | [-20.41, 22.54] |
| 6-months Post-TKA | 63.4 ± 15.7 | 63.4 ± 22.5 | 0.999 | 0.0 | [-18.11, 18.09] | |
| 24-months Post-TKA | 67.3 ± 17.3 | 79.1 ± 13.8 | 0.315 | -11.8 | [-36.93, 13.40] | |
| KOOS-ADL (points) | Pre-TKA | 56.1 ± 20.4 | 55.9 ± 24.2 | 0.984 | 0.2 | [-18.51, 18.88] |
| 6-months Post-TKA | 79.2 ± 17.1 | 76.6 ± 26.8 | 0.641 | 2.6 | [-10.72, 15.97] | |
| 24-months Post-TKA | 78.7 ± 14.5 | 83.9 ± 10.6 | 0.478 | -5.2 | [-21.13, 10.70] | |
| KOOS-QOL (points) | Pre-TKA | 24.4 ± 17.7 | 27.5 ± 33.2 | 0.756 | -3.0 | [-23.10, 17.01] |
| 6-months Post-TKA | 56.8 ± 22.4 | 50.5 ± 20.8 | 0.355 | 6.3 | [-9.43, 21.97] | |
| 24-months Post-TKA | 63.2 ± 26.3 | 67.7 ± 21.3 | 0.759 | -4.5 | [-36.12, 27.19] |
Average functional measures within groups of participants with modules that were (Proper) or were not (Poor) organized like healthy controls at each timepoint (estimated mean ± 1 standard deviation).
† Clinically meaningful difference in function between the Proper and Poor organization groups.
Count of participants with changes in modules.
| Pre-TKA to 6-m Post-TKA | 6-m to 24-m Post-TKA | Pre-TKA to 24-m Post-TKA | ||
|---|---|---|---|---|
| n = 19 | n = 10 | n = 10 | ||
| Number of Modules | Increase | 3 (15.8%) | 1 (10.0%) | 4 (40.0%) |
| No Change | 12 (63.2%) | 7 (70.0%) | 4 (40.0%) | |
| Decrease | 4 (21.1%) | 2 (20.0%) | 2 (20.0%) | |
| Proper vs. Poor Organization | Improved | 5 (26.3%) | 2 (20.0%) | 4 (40.0%) |
| No Change | 12 (63.2%) | 6 (60.0%) | 5 (50.0%) | |
| Worsened | 2 (10.5%) | 2 (20.0%) | 1 (10.0%) | |
| Any Module Characteristic | Change | 12 (63.2%) | 8 (80.0%) | 10 (100.0%) |
| No Change | 7 (36.8%) | 2 (20.0%) | 0 (0.0%) |
Number of participants (%) that were present at multiple time points and demonstrated changes in module characteristics. Proper organization describes participants whose organization matched those of healthy controls for all modules. Poor organization describes participants with at least 1 module that was not organized like healthy controls. Participants listed as having a change in “Any Module Characteristic” had a change in the number of modules and/or the organization of at least 1 module compared to healthy controls.